This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25-OH vitamin D3. No side-effects were observed. Although vitamin D3 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of longstanding remission in a patient with CMML. This 'differentiation therapy' might be considered as a possible alternative in the management of this disease.
|Original language||English (US)|
|Number of pages||2|
|Journal||British Journal of Haematology|
|State||Published - Dec 1993|
All Science Journal Classification (ASJC) codes